Aluminum trichloride inhibits osteoblastic differentiation through inactivation of Wnt/β-catenin signaling pathway in rat osteoblasts

Environmental Toxicology and Pharmacology

Volumn 42, Issue , 2016, Pages 198-204

  Cao, Zheng ^a   Fu, Yang ^a   Sun, Xudong ^a   Zhang, Qiuyue ^a   Xu, Feibo ^a   Li, Yanfei ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

Author keywords

Aluminum trichloride; Osteoblastic differentiation; Rat osteoblasts; Wnt catenin pathway

Indexed keywords

ALUMINUM DERIVATIVE; ALUMINUM TRICHLORIDE; BETA CATENIN; COLLAGEN TYPE 1; DICKKOPF 1 PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; UNCLASSIFIED DRUG; WNT3A PROTEIN; ALUMINUM CHLORIDE; CHLORIDE; DANGEROUS GOODS;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; EXPOSURE; IC50; IMMUNOFLUORESCENCE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WNT SIGNALING PATHWAY; ANIMAL; BONE DEVELOPMENT; DANGEROUS GOODS; DRUG EFFECTS; METABOLISM; TOXICITY;

ALUMINUM COMPOUNDS; ANIMALS; CELL DIFFERENTIATION; CHLORIDES; COLLAGEN TYPE I; HAZARDOUS SUBSTANCES; OSTEOBLASTS; OSTEOGENESIS; RATS; WNT SIGNALING PATHWAY;

EID: 84957796969     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2015.11.023     Document Type: Article

References (67)

1. Arioka M., Takahashi-Yanaga F., Sasaki M., Yoshihara T., Morimoto S., Hirata M., Mori Y., Sasaguri T. Acceleration of bone regeneration by local application of lithium: Wnt signal-mediated osteoblastogenesis and Wnt signal-independent suppression of osteoclastogenesis. Biochem. Pharmacol. 2014, 90:397-405.
2. Bain G., Muller T., Wang X., Papkoff J. Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction. Biochem. Biophys. Res. Commun. 2003, 301:84-91.
3. Bancroft G.N., Sikavitsas V.I., van den Dolder J., Sheffield T.L., Ambrose C.G., Jansen J.A., Mikos A.G. Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:12600-12605.
4. Baron R., Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat. Med. 2013, 19:179-192.
5. Bellows C.G., Aubin J.E., Heersche J.N.M. Aluminum inhibits both initiation and progression of mineralization of osteoid nodules formed in differentiating rat calvaria cell cultures. J. Bone Miner. Res. 1995, 10:2011-2016.
6. Bennett C.N., Longo K.A., Wright W.S., Suva L.J., Lane T.F., Hankenson K.D., Mac-Dougald O.A. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:3324-3329.
7. Bialek P., Kern B., Yang X., Schrock M., Sosic D., Hong N., Wu H., Yu K., Ornitz D.M., Olson E.N., Justice M.J., Karsenty G. A twist code determines the onset of osteoblast differentiation. Dev. Cell 2004, 6:423-435.
8. Blair H.C., Finch J.L., Avioli R., Crouch E.C., Slatopolsky E., Teitelbaum S.L. Micromolar aluminum levels reduce 3H-thymidine incorporation by cell line UMR 106-01. Kidney Int. 1989, 35:1119-1125.
9. Borgmann U., Couillard Y., Grapentine L.C. Relative contribution of food and water to 27 metals and metalloids accumulated by caged hyalella azteca in two rivers affected by metal mining. Environ. Pollut. 2007, 145:753-765.
10. Boullemant A. PM2.5 emissions from aluminum smelters: coefcients and environmental impact. J. Air Waste Manage. Assoc. 2011, 61:311-318.
11. Boyce B.F., Byars J., Mcwilliams S., Mocan M.Z., Elder H.Y., Boyle I.T., Junor B.J. Histological and electron microprobe studies of mineralisation in aluminium-related osteomalacia. J. Clin. Pathol. 1992, 45:502-508.
12. Bushinsky D.A. Bone disease in moderate renal failure: cause, nature and prevention. Annu. Rev. Med. 1997, 48:167-176.
13. Cao H., Qiao L., Zhang H., Chen J. Exposure and risk assessment for aluminium and heavy metals in Puerh tea. Sci. Total Environ. 2010, 408:2777-2784.
14. 2+/CaMKII signal pathway. Biol. Trace Elem. Res. 2015, 10.1007/s12011-015-0417-1.
15. Chamorro M.N., Schwartz D.R., Alin V., Brivanlou A.H., Cho K.R., Varmus H.E. FGF-20 and dkk1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development. EMBO J. 2005, 24:73-84.
16. Chen J.R., Lazarenko O.P., Wu X., Kang J., Blackburn M.L., Shankar K., Badger T.M., Ronis M.J. Dietary-induced serum phenolic acids promote bone growth via p38 MAPK/β-catenin canonical Wnt signaling. J. Bone Miner Res. 2010, 25:2399-2411.
17. Cho S.W., Yang J.Y., Sun H.J., Jung J.Y., Her S.J., Cho H.Y., Choi H.J., Kim S.W., Kim S.Y., Shin C.S. Wnt inhibitory factor (WIF)-inhibits osteoblastic differentiation in mouse embryonic mesenchymal cells. Bone 2009, 44:1069-1077.
18. Dabeka R., Fouquet A., Belisle S., Turcotte S. Lead, cadmium and aluminum in Canadian infant formulae, oral electrolytes and glucose solutions. Food Addit. Contam. A 2011, 28:744-753.
19. Day T.F., Guo X., Garrett-Beal L., Yang Y. Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell 2005, 8:739-750.
20. Deschaseaux F., Sensebe L., Heymann D. Mechanisms of bone repair and regeneration. Trends Mol. Med. 2009, 15:417-429.
21. Ducy P., Schinke T., Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000, 289:1501-1504.
22. Fujita K., Janz S. Attenuation of wnt signaling by Dkk-and -regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF. Mol. Cancer 2007, 6:5158-5164.
23. Fukuda T., Kokabu S., Ohte S., Sasanuma H., Kanomata K., Yoneyama K., Kato H., Akita M., Oda H., Katagiri T. Canonical Wnts and BMPs cooperatively induce osteoblastic differentiation through a GSK3β-dependent and β-catenin-independent mechanism. Differentiation 2010, 80:46-52.
24. Ganrot P.O. Metabolism and possible health efects of aluminum. Environ. Health Persp. 1986, 65:363-441.
25. Gaur T., Lengner C.J., Hovhannisyan H., Bhat R.A., Bodine P.V., Komm B.S., Javed A., van Wijnen A.J., Stein J.L., Stein G.S., Lian J.B. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J. Biol. Chem. 2005, 280:33132-33140.
26. Glass D.A., Karsenty G. In vivo analysis of Wnt signaling in bone. Endocrinology 2007, 148:2630-2634.
27. Gordon M.D., Nusse R. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J. Biol. Chem. 2006, 281:22429-22433.
28. Guo A.J., Choi R.C., Cheung A.W., Chen V.P., Xu S.L., Dong T.T., Chen J.J., Tsim K.W. Baicalin, a flavone, induces the differentiation of cultured osteoblasts: an action via the Wnt/β-catenin signaling. J. Biol. Chem. 2011, 286:27882-27893.
29. Hill T.P., Spater D., Taketo M.M., Birchmeier W., Hartmann C. Canonical Wnt/β-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev. Cell 2005, 8:727-738.
30. Hodsman A.B., Sherrard D.J., Alfrey A.C., Ott S., Brickman A.S., Miller N.L., Maloney N.A., Coburn J.W. Bone aluminum and histomorphometric features of renal osteodystrophy. J. Clin. Endocr. Metab. 1982, 54:539-546.
31. Holmen S.L., Zylstra C.R., Mukherjee A., Sigler R.E., Faugere M.C., Bouxsein M.L., Deng L., Clemens T.L., Nilliams B.O. Essential role of β-catenin in postnatal bone acquisition. J. Biol. Chem. 2005, 280:21162-21168.
32. Hu H., Hilton M.J., Tu X., Yu K., Ornitz D.M., Long F. Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 2005, 132:49-60.
33. Jeffery E.H., Abreo K., Burgess E., Cannata J., Greger J.L. Systemic aluminum toxicity: effects on bone, hematopoietic tissue, and kidney. J. Toxicol. Environ. Health 1996, 48:649-666.
34. Jorgetti V., Soeiro N.M., Mendes V., Pereira R.C., Crivellari M.E., Coutris G., Borelli A., Leite M.O., Nussenzweig I., Marcondes M. Aluminium-related osteodystrophy and desferrioxamine treatment: role of phosphorus. Nephrol. Dial. Transplant. 1994, 9:668-674.
35. Karlsson M., Pålsgård E., Wilshaw P.R., Di Silvio L. Initial in vitro interaction of osteoblasts with nano-porous alumina. Biomaterials 2003, 24:3039-3046.
36. Kasai K., Hori M.T., Goodman W.G. Transferrin enhances the antiproliferative effect of aluminum on osteoblast-like cells. Am. J. Physiol. 1991, 260:537-543.
37. Kim H.J., Kim S.H., Kim M.S., Lee E.J., Oh H.G., Oh W.M., Park S.W., Kim W.J., Lee G.J., Choi N.G., Koh J.T., Dinh D.B., Hardin R.R., Johnson K., Sylvia V.L., Schmitz J.P., Dean D.D. Varying Ti-6Al-4V surface roughness induces different early morphologic and molecular responses in MG63 osteoblast-like cells. J. Biomed. Mater. Res. A 2005, 74:366-373.
38. Komori T. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res. 2010, 339:189-195.
39. Krewski D., Yokel R.A., Nieboer E., Borchelt D., Cohen J., Harry J., Kacew S., Lindsay J., Mahfouz A.M., Rondeau V. Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J. Toxicol. Environ. Health B: Crit. Rev. 2007, 10:1-269.
40. Lau K.H., Yoo A., Shu P.W. Aluminum stimulates the proliferation and differentiation of osteoblasts in vitro by a mechanism that is different from fluoride. Mol. Cell Biochem. 1991, 105:93-105.
41. Li X., Hu C., Zhu Y., Sun H., Li Y., Zhang Z. Effects of aluminum exposure on bone mineral density, mineral, and trace elements in rats. Biol. Trace Elem. Res. 2011, 143:378-385.
42. Li X., Han Y., Guan Y., Zhang L., Bai C., Li Y. Aluminum induces osteoblast apoptosis through the oxidative stress-mediated JNK signaling pathway. Biol. Trace Elem. Res. 2012, 150:502-508.
43. Lieberherr M., Grosse B., Cournot-Witmer G., Hermann-Erlee M.P., Balsan S. Aluminum action on mouse bone cell metabolism and response to PTH and 1,25(OH)2D3. Kidney Int. 1987, 31:736-743.
44. López-Herradón A., Portal-Núñez S., García-Martín A., Lozano D., Pérez-Martínez F.C., Ceña V., Esbrit P. Inhibition of the canonical wnt pathway by high glucose can be reversed by parathyroid hormone-related protein in osteoblastic cells. J. Cell Biochem. 2013, 114:1908-1916.
45. Malluche H.H., Faugere M.C., Friedler R.M., Matthews C., Fanti P. Calcitriol, parathyroid hormone, and accumulation of aluminum in bone in dogs with renal failure. J. Clin. Invest. 1987, 79:754-761.
46. Mao B., Wu W., Li Y., Hoppe D., Stannek P., Glinka A., Nihrs C. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 2001, 411:321-325.
47. Mao J., Wang J., Liu B., Pan W., Farr G.H., Flynn C., Yuan H., Takada S., Kimelman D., Li L., Wu D. Low-density lipoprotein receptor-related protein-binds to Axin and regulates the canonical Wnt signaling pathway. Mol. Cell 2001, 7:801-809.
48. Matsuzaki E., Takahashi-Yanaga F., Miwa Y., Hirata M., Watanabe Y., Sato N., Morimoto S., Hirofuji T., Maeda K., Sasaguri T. Differentiation-inducing factor-alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines. J. Bone Miner. Res. 2006, 21:1307-1316.
49. Ohno K., Ishikawa K., Kurosawa Y., Matsui Y., Matsushita T., Magara Y. Exposure assessment of metal intakes from drinking water relative to those from total diet in Japan. Water Sci. Technol. 2010, 62:2694-2701.
50. Park K.H., Kang J.W., Lee E.M., Kim J.S., Rhee Y.H., Kim M., Jeong S.J., Park Y.G., Kim S.H. Melatonin promotes osteoblastic differentiation through the BMP/ERK/Wnt signaling pathways. J. Pineal. Res. 2011, 51:187-194.
51. Pan L., Shi X., Liu S., Guo X., Zhao M., Cai R., Sun G. Fluoride promotes osteoblastic differentiation through canonical wnt/β-catenin signaling pathway. Toxicol. Lett. 2014, 225:34-42.
52. Priest N.D. The biological behaviour and bioavailability of aluminium in man, with special reference to studies employing aluminium-26 as a tracer: review and study update. J. Environ. Montior. 2004, 6:375-403.
53. Prince M., Banerjee C., Javed A., Green J., Lian J.B., Stein G.S., Bodine P.V., Komm B.S. Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts. J. Cell Biochem. 2001, 80:424-440.
54. Qiang Y.W., Barlogie B., Rudikoff S., Shaughnessy J.D. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma. Bone 2008, 42:669-680.
55. Quarles L.D. Attenuated bone aluminum deposition in nonuremic beagles with reduced bone remodeling. Am. J. Physiol. 1990, 258:576-581.
56. Sato M.M., Nakashima A., Nashimoto M., Yawaka Y., Tamura M. Bone morphogenetic protein-enhances Wnt/β-catenin signaling-induced osteoprotegerin expression. Genes Cells 2009, 14:141-153.
57. Sedman A.B., Alfrey A.C., Miller N., Goodman W.G. Tissue and cellular basis for impaired bone formation in aluminum-related osteomalacia in the pig. J. Clin. Invest. 1987, 79:86-92.
58. Shin H., Zygourakis K., Farach-Carson M.C., Yaszemski M.J., Mikos A.G. Modulation of differentiation and mineralization of marrow stromal cells cultured on biomimetic hydrogels modified with Arg-Gly-Asp containing peptides. J. Biomed. Mater. Res. 2004, 69:535-543.
59. Skalny A.V., Skalnaya M.G., Tinkov A.A., Serebryansky E.P., Demidov V.A., Lobanova Y.N., Grabeklis A.R., Berezkina E.S., Gryazeva I.V., Skalny A.A., Nikonorov A.A. Reference values of hair toxic trace elements content in occupationally non-exposed Russian population. Environ. Toxicol. Pharmacol. 2015, 40:18-21.
60. Smith R.W. Kinetic aspects of aqueous aluminum chemistry: environmental implications. Coord. Chem. Rev. 1996, 149:81-93.
61. Song Y., Yang J., Morita Y., Song G. Effect of the nanostructure of porous alumina on growth behavior of MG63 osteoblast-like cells. J. Biosci. Bioeng. 2013, 116:509-515.
62. Tian Y., Xu Y., Fu Q., He M. Parathyroid hormone regulates osteoblast differentiation in a Wnt/β-catenin-dependent manner. Mol. Cell Biochem. 2011, 355:211-216.
63. Wang Z., Guo J. Mechanical induction of BMP-in osteocyte blocks glucocorticoid-induced apoptosis through PI3K/AKT/GSK3β pathway. Cell Biochem. Biophys. 2013, 67:567-574.
64. 2 into the lower airways. J. Environ. Monit. 2010, 12:448-454.
65. Willhite C.C., Karyakina N.A., Yokel R.A., Yenugadhati N., Wisniewski T.M., Arnold I.M., Momoli F., Krewski D. Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts. Crit. Rev. Toxicil. 2014, 44:1-80.
66. Yokel R.A., Mcnamara P.J. Aluminium toxicokinetics: an updated minireview. Pharmacol. Toxicol. 2001, 88:159-167.
67. Zeng L., Fagotto F., Zhang T., Hsu W., Vasicek T.J., Perry W.L., Lee J.J., Tilghman S.M., Gumbiner B.M., Costantini F. The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 1997, 90:181-192.